Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder by Race and Ethnicity and Insurance Type.
- Published in:
- JAMA Network Open, 2025, v. 8, n. 6, p. e2518493, doi. 10.1001/jamanetworkopen.2025.18493
- By:
- Publication type:
- Article
Works about NALTREXONE
Results: 1749
1
2
Availability of Medications for Opioid Use Disorder in Opioid Treatment Programs.
- Published in:
- JAMA Network Open, 2025, v. 8, n. 6, p. e2517616, doi. 10.1001/jamanetworkopen.2025.17616
- By:
- Publication type:
- Article
3
Ongoing Gaps in Buprenorphine Treatment—Urgency and Opportunity.
- Published in:
- 2025
- By:
- Publication type:
- Opinion
4
Otrstik Hastalarda Kendine Zarar Verme Davraışında Naltrekson Tedavisi ve İki Olgu Sunumu.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
5
The Neural Inhibition of Learning Increases Asset Market Bubbles: Experimental Evidence.
- Published in:
- Journal of Behavioral Finance, 2017, v. 18, n. 1, p. 114, doi. 10.1080/15427560.2016.1238372
- By:
- Publication type:
- Article
6
Topiramate compares favorably to naltrexone for alcohol use disorder.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 10, p. 3, doi. 10.1002/pu.31213
- Publication type:
- Article
7
Post‐hospital initiation of medication for AUD reduces rehospitalization.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 8, p. 7, doi. 10.1002/pu.31191
- Publication type:
- Article
8
Naltrexone, acamprosate show strongest results in review of alcohol use disorder treatments.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 3, p. 4, doi. 10.1002/pu.31133
- Publication type:
- Article
9
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 11, p. 9, doi. 10.1002/pu.31092
- Publication type:
- Article
10
Naltrexone plus bupropion effective as maintenance therapy for binge eating disorder.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 10, p. 6, doi. 10.1002/pu.31073
- Publication type:
- Article
11
Disruption in medication for OUD exacerbates risk of overdose.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 7, p. 8, doi. 10.1002/pu.31039
- Publication type:
- Article
12
Both naltrexone‐bupropion and weight loss therapy effective for binge eating disorder.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 2, p. 4, doi. 10.1002/pu.30973
- Publication type:
- Article
13
Combination of varenicline and naltrexone may benefit drinking, but not smoking, outcomes.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 10, p. 3, doi. 10.1002/pu.30779
- Publication type:
- Article
14
Harm reduction approach effective for homeless with alcohol use disorder.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 7, p. 3, doi. 10.1002/pu.30741
- Publication type:
- Article
15
The ghost of Heisenberg, or: methamphetamine, again.
- Published in:
- 2021
- By:
- Publication type:
- Film/TV Criticism and Review
16
Bupropion plus naltrexone shows some benefit in stimulant use disorder.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 5, p. 1, doi. 10.1002/pu.30713
- Publication type:
- Article
17
Comparative study shows superiority of medications for opioid use disorder.
- Published in:
- Brown University Psychopharmacology Update, 2020, v. 31, n. 6, p. 4, doi. 10.1002/pu.30582
- Publication type:
- Article
18
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2019, v. 30, n. 9, p. 9, doi. 10.1002/pu.30479
- Publication type:
- Article
19
Injectable naltrexone does not increase comorbid symptoms in opioid addiction.
- Published in:
- Brown University Psychopharmacology Update, 2019, v. 30, n. 4, p. 7, doi. 10.1002/pu.30413
- Publication type:
- Article
20
Treatment retention, drug‐use outcomes improved with injectable form of naltrexone.
- Published in:
- Brown University Psychopharmacology Update, 2019, v. 30, n. 2, p. 1, doi. 10.1002/pu.30389
- Publication type:
- Article
21
Antidepressant effect of ketamine requires opioid system activation.
- Published in:
- Brown University Psychopharmacology Update, 2018, v. 29, n. 12, p. 4, doi. 10.1002/pu.30378
- Publication type:
- Article
22
Medications for substance use disorders lower risk of crime, suicidal behavior.
- Published in:
- Brown University Psychopharmacology Update, 2018, v. 29, n. 11, p. 1, doi. 10.1002/pu.30367
- Publication type:
- Article
23
Limited evidence of baclofen's effectiveness in alcohol disorder treatment.
- Published in:
- Brown University Psychopharmacology Update, 2018, v. 29, n. 7, p. 4, doi. 10.1002/pu.30337
- Publication type:
- Article
24
Treatment initiation cited in study comparing extended‐release naltrexone, buprenorphine.
- Published in:
- Brown University Psychopharmacology Update, 2018, v. 29, n. 3, p. 1, doi. 10.1002/pu.30300
- Publication type:
- Article
25
Injectable naltrexone found as effective as buprenorphine in noninferiority trial.
- Published in:
- Brown University Psychopharmacology Update, 2018, v. 29, n. 2, p. 1, doi. 10.1002/pu.30292
- Publication type:
- Article
26
Initiation to injectable naltrexone likelier after rapid detoxification from opioids.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 5, p. 1, doi. 10.1002/pu.30227
- Publication type:
- Article
27
Research Roundup.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 1, p. 7, doi. 10.1002/pu.30200
- Publication type:
- Article
28
Extended-release naltrexone reduces opioid relapse in justice population.
- Published in:
- Brown University Psychopharmacology Update, 2016, v. 27, n. 7, p. 1, doi. 10.1002/pu.30151
- Publication type:
- Article
29
Naltrexone reduces drug craving in methamphetamine-dependent group.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 11, p. 7
- Publication type:
- Article
30
Naltrexone extended-release injectable (generic).
- Published in:
- 2015
- Publication type:
- Product Review
31
Research Roundup. Maintenance naltrexone reduces reinforcing effects of marijuana.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 9, p. 7
- Publication type:
- Article
32
RESEARCH ROUNDUP.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 7, p. 7, doi. 10.1002/pu.30062
- Publication type:
- Article
33
No difference between citalopram plus naltrexone, naltrexone alone for depression with alcohol use.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 6, p. 3, doi. 10.1002/pu.30052
- Publication type:
- Article
34
From the FDA.
- Published in:
- Brown University Psychopharmacology Update, 2014, v. 25, n. 12, p. 8
- Publication type:
- Article
35
Research Roundup. Hospital costs decline dramatically with naltrexone implant for alcohol use.
- Published in:
- Brown University Psychopharmacology Update, 2014, v. 25, n. 9, p. 7
- Publication type:
- Article
36
Research Roundup. Alcohol use medications result in drinking reduction.
- Published in:
- Brown University Psychopharmacology Update, 2014, v. 25, n. 8, p. 7
- Publication type:
- Article
37
Naltrexone extended-release injectable (generic).
- Published in:
- Brown University Psychopharmacology Update, 2014, v. 25, p. 1
- Publication type:
- Article
38
Naltrexone, exposure therapy have role in treating PTSD, alcohol dependence.
- Published in:
- Brown University Psychopharmacology Update, 2013, v. 24, n. 11, p. 1
- Publication type:
- Article
39
Naltrexone efficacy may decrease over time.
- Published in:
- Brown University Psychopharmacology Update, 2013, v. 24, n. 6, p. 8
- Publication type:
- Article
40
Naltrexone, smoking cessation and weight gain.
- Published in:
- Brown University Psychopharmacology Update, 2013, v. 24, n. 3, p. 8
- Publication type:
- Article
41
Smoking impacts naltrexone effectiveness for alcohol dependence.
- Published in:
- Brown University Psychopharmacology Update, 2013, v. 24, n. 3, p. 7
- Publication type:
- Article
42
Naltrexone for smoking cessation and weight gain.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 12, p. 7
- Publication type:
- Article
43
Naltrexone implant shows results for treatment of polydrug abuse.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 8, p. 1
- Publication type:
- Article
44
Short-term benefits of add-on gabapentin with naltrexone.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 10, p. 7
- Publication type:
- Article
45
Naltrexone extended-release injectable (generic): VIVITROL (BRAND).
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, p. 1
- Publication type:
- Article
46
Comments by George E. Woody, M.D on the Krupitsky et al. study in Lancet.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
47
New treatment option for opioid-dependent patients with injectable ER naltrexone.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 9, p. 1
- Publication type:
- Article
48
From the FDA.
- Published in:
- Brown University Psychopharmacology Update, 2010, v. 21, n. 12, p. 8
- Publication type:
- Article
49
Sertraline plus naltrexone superior for depressed alcohol-dependent patients.
- Published in:
- Brown University Psychopharmacology Update, 2010, v. 21, n. 9, p. 1
- Publication type:
- Article
50
Oral naltrexone versus naltrexone implant for heroin dependence.
- Published in:
- Brown University Psychopharmacology Update, 2010, v. 21, n. 1, p. 5
- Publication type:
- Article